NAUT Nautilus Biotechnology Inc Future Profit

Corporate emblem and logo of nautilus.bio (NAUT)

The current valuation of future earnings on the GURU.Markets daily chart reflects the impact of the Inertia platform, which generates stable subscription revenue across R&D centers. The value describes the current level of expectations, supported by unique protein analysis precision for new drug development. High standards for upgraded equipment and capacity utilization provide the technological foundation for the growth of Nautilus Biotechnology (NAUT).

NAUT: Nautilus Biotechnology Inc Company Profit Forecast 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company Nautilus Biotechnology Inc (NAUT)

Initial company analysis:Nautilus Biotechnology, Inc.
Brand item of Nautilus Biotechnology, Inc.

Long-term investing requires protecting capital from systemic business decline. For Nautilus Biotechnology (NAUT), this entails evaluating the effectiveness of proteomics alliances and the search for oncology targets. Analyst earnings expectations reflect the discounted sum of future net income minus all expenses. Growth in this indicator confirms the commercial viability of biotechnological developments. Positive momentum creates an optimistic asset profile.

Competitor analysis for Nautilus Biotechnology

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings